Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs Warfarin for LAA Thrombus in AF
NCT03792152Unknown
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Jun 2019
- Primary completion
- Jan 2022
01
Overview
Randomised, open-label trial of rivaroxaban in Atrial fibrillation (AFib) and left atrial appendage thrombus (2 arms), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoint: Number of patients with complete thrombus dissolution within 3 to 6 weeks. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
Atrial fibrillation (AFib)left atrial appendage thrombus
Beyond the preview
Go deeper on NCT03792152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03792152.